Literature DB >> 4834293

Insulin and glucagon degradation by the same enzyme.

W C Duckworth, A E Kitabchi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4834293     DOI: 10.2337/diab.23.6.536

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  19 in total

1.  Clearance of immunoreactive somatostatin by perfused rat liver.

Authors:  H Sacks; L C Terry
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

Review 2.  Physiological functions of endosomal proteolysis.

Authors:  T Berg; T Gjøen; O Bakke
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

3.  Independance of glucagon and insulin handling by the isolated perfused dog kidney.

Authors:  P J Lefebvre; A S Luyckx; A H Nizet
Journal:  Diabetologia       Date:  1976-08       Impact factor: 10.122

4.  Initial site of insulin cleavage by insulin protease.

Authors:  W C Duckworth; F B Stentz; M Heinemann; A E Kitabchi
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

5.  Glucagon increases insulin levels by stimulating insulin secretion without effect on insulin clearance in mice.

Authors:  Gina Song; Giovanni Pacini; Bo Ahrén; David Z D'Argenio
Journal:  Peptides       Date:  2016-12-21       Impact factor: 3.750

6.  Glucagon receptor of human liver. Studies of its molecular weight and binding properties, and its ability to activate hepatic adenylyl cyclase of non-obese and obese subjects.

Authors:  J N Livingston; K Einarsson; L Backman; S Ewerth; P Arner
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

7.  Insulin degrading enzyme activity and insulin binding of erythrocytes in normal subjects and Type 2 (non-insulin-dependent) diabetic patients.

Authors:  E Standl; H J Kolb
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

8.  Glucagon sensitivity and clearance in type 1 diabetes: insights from in vivo and in silico experiments.

Authors:  Ling Hinshaw; Ashwini Mallad; Chiara Dalla Man; Rita Basu; Claudio Cobelli; Rickey E Carter; Yogish C Kudva; Ananda Basu
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-07-07       Impact factor: 4.310

9.  Insulin degrading enzyme induces a conformational change in varicella-zoster virus gE, and enhances virus infectivity and stability.

Authors:  Qingxue Li; Mir A Ali; Kening Wang; Dean Sayre; Frederick G Hamel; Elizabeth R Fischer; Robert G Bennett; Jeffrey I Cohen
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

10.  Receptor- and non-receptor-mediated uptake and degradation of insulin by hepatocytes.

Authors:  D B Donner
Journal:  Biochem J       Date:  1982-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.